{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T09:16:04Z","timestamp":1784970964577,"version":"3.55.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:00:00Z","timestamp":1706140800000},"content-version":"vor","delay-in-days":24,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Brazilian Journal of Infectious Diseases"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.bjid.2024.103719","type":"journal-article","created":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T15:56:31Z","timestamp":1707321391000},"page":"103719","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Safety of the yellow fever vaccine in people living with HIV: a longitudinal study exploring post-vaccination viremia and hematological and liver kinetics"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3637-0623","authenticated-orcid":false,"given":"Edwiges","family":"Motta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4656-1914","authenticated-orcid":false,"given":"Luiz Antonio B.","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana M. Bispo de","family":"Filippis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcellus","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana","family":"Pedro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5230-0003","authenticated-orcid":false,"given":"Sandra W.","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta Cristina de Oliveira","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3493-105X","authenticated-orcid":false,"given":"Ygara da Silva","family":"Mendes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3692-5155","authenticated-orcid":false,"given":"Beatriz","family":"Grinsztejn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7154-8151","authenticated-orcid":false,"given":"Lara E.","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjid.2024.103719_bib0001","series-title":"Vaccine Market Report Highlights Inequitable Global Distribution","year":"2020"},{"key":"10.1016\/j.bjid.2024.103719_bib0002","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nri2629","article-title":"Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology","volume":"9","author":"Pulendran","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bjid.2024.103719_bib0003","series-title":"A Global Strategy to Eliminate Yellow Fever Epidemics (EYE) 2017\u20132026","first-page":"54","year":"2018"},{"key":"10.1016\/j.bjid.2024.103719_bib0004","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jcv.2014.08.030","article-title":"Vasconcelos PFC. Yellow fever","volume":"64","author":"Monath","year":"2015","journal-title":"Journal of Clinical Virology"},{"key":"10.1016\/j.bjid.2024.103719_bib0005","series-title":"Of\u00edcio Circular n 136","year":"2019"},{"key":"10.1016\/j.bjid.2024.103719_bib0006","series-title":"Vaccine Information | Yellow Fever | CDC","year":"2020"},{"key":"10.1016\/j.bjid.2024.103719_bib0007","series-title":"Manual De Vigil\u00e2ncia Epidemiol\u00f3gica De Eventos Adversos P\u00f3s-Vacina\u00e7\u00e3o","year":"2021"},{"key":"10.1016\/j.bjid.2024.103719_bib0008","doi-asserted-by":"crossref","DOI":"10.1097\/QAD.0000000000001963","article-title":"Immunogenicity and safety of yellow fever vaccine in HIV-1-infected patients: ANRS EP46 NOVAA","author":"Colin De Verdiere","year":"2018","journal-title":"AIDS"},{"key":"10.1016\/j.bjid.2024.103719_bib0009","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1086\/597006","article-title":"Immunogenicity and safety of yellow fever vaccination for 102 HIV-infected patients","volume":"48","author":"Veit","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2024.103719_bib0010","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/cid\/cix960","article-title":"Long-term immune response to yellow fever vaccination in Human Immunodeficiency Virus (HIV) \u2013 infected individuals depends on HIV RNA suppression status: implications for vaccination schedule","volume":"66","author":"Veit","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2024.103719_bib0011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005219","article-title":"CD4\/CD8 ratio and KT ratio predict yellow fever vaccine immunogenicity in HIV-infected patients","volume":"10","author":"Avelino-Silva","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.bjid.2024.103719_bib0012","series-title":"Cochrane Database of Systematic Reviews","article-title":"Yellow fever vaccine for patients with HIV infection. In: the Cochrane Collaboration","author":"Barte","year":"2014"},{"key":"10.1016\/j.bjid.2024.103719_bib0013","first-page":"131","article-title":"Fatal myeloencephalitis following yellow fever vaccination in a case with HIV infection","volume":"85","author":"Kengsakul","year":"2002","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.bjid.2024.103719_bib0014","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1080\/21645515.2015.1022700","article-title":"Serious adverse events associated with yellow fever vaccine","volume":"11","author":"de Menezes Martins","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.bjid.2024.103719_bib0015","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.2147\/DDDT.S99600","article-title":"Yellow fever vaccine-associated viscerotropic disease: current perspectives","volume":"10","author":"Thomas","year":"2016","journal-title":"DDDT"},{"key":"10.1016\/j.bjid.2024.103719_bib0016","series-title":"Vaccines","first-page":"1181","article-title":"Yellow fever vaccines","author":"Plotkin","year":"2018"},{"key":"10.1016\/j.bjid.2024.103719_bib0017","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1128\/JCM.01775-10","article-title":"Detection of yellow fever 17D genome in urine","volume":"49","author":"Domingo","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bjid.2024.103719_bib0018","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1016\/j.vaccine.2011.02.075","article-title":"Persistence of yellow fever vaccine RNA in urine","volume":"29","author":"Mart\u00ednez","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.bjid.2024.103719_bib0019","doi-asserted-by":"crossref","first-page":"5038","DOI":"10.1016\/j.vaccine.2012.04.067","article-title":"Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data","volume":"30","author":"Gershman","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.bjid.2024.103719_bib0020","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1097\/QAD.0000000000003696","article-title":"Immunogenicity and reactogenicity of yellow fever vaccine in people with HIV","volume":"37","author":"Motta","year":"2023","journal-title":"AIDS"},{"key":"10.1016\/j.bjid.2024.103719_bib0021","unstructured":"Bio-Manguinhos (Fiocruz). Vacina de Febre Amarela (Atenuada). Bula. Bras\u00edlia, Anvisa, 2015."},{"key":"10.1016\/j.bjid.2024.103719_bib0022","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.biologicals.2012.09.005","article-title":"Evaluation of accuracy and reliability of the plaque reduction neutralization test (micro-PRNT) in detection of yellow fever virus antibodies","volume":"40","author":"Sim\u00f5es","year":"2012","journal-title":"Biologicals"},{"key":"10.1016\/j.bjid.2024.103719_bib0023","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1590\/S0001-37652008000200009","article-title":"Limited replication of yellow fever 17DD and 17D-Dengue recombinant viruses in rhesus monkeys","volume":"80","author":"Trindade","year":"2008","journal-title":"An Acad Bras Cienc"},{"key":"10.1016\/j.bjid.2024.103719_bib0024","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/jmp.12501","article-title":"Safety and immunogenicity of 17DD attenuated yellow fever vaccine in howler monkeys (Alouatta spp.)","volume":"50","author":"Tavares da Silva Fernandes","year":"2021","journal-title":"J Med Primatol"},{"key":"10.1016\/j.bjid.2024.103719_bib0025","series-title":"Rio de Janeiro: Bio-Manguinhos","year":"2020"},{"key":"10.1016\/j.bjid.2024.103719_bib0026","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4103\/0974-777X.56257","article-title":"Anamnestic immune response to dengue and decreased severity of yellow fever","volume":"1","author":"Izurieta","year":"2009","journal-title":"J Glob Infect Dis"},{"key":"10.1016\/j.bjid.2024.103719_bib0027","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4269\/ajtmh.1975.24.115","article-title":"The relative resistance of dengue-immune monkeys to yellow fever virus*","volume":"24","author":"Theiler","year":"1975","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.bjid.2024.103719_bib0028","doi-asserted-by":"crossref","first-page":"879","DOI":"10.4161\/hv.22982","article-title":"17DD yellow fever vaccine: a double blind, randomized clinical trial of immunogenicity and safety on a dose-response study","volume":"9","author":"Martins","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.bjid.2024.103719_bib0029","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.vaccine.2010.08.046","article-title":"Characterization of main cytokine sources from the innate and adaptive immune responses following primary 17DD yellow fever vaccination in adults","volume":"29","author":"Silva","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.bjid.2024.103719_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157385","article-title":"Neutropenia as an adverse event following vaccination: results from randomized clinical trials in healthy adults and systematic review","volume":"11","author":"Muturi-Kioi","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bjid.2024.103719_bib0031","article-title":"Yellow fever vaccination in Brazil: short-term safety and immunogenicity in juvenile autoimmune rheumatic diseases","volume":"10","author":"Emi Aikawa","year":"2021","journal-title":"Vaccine X"},{"key":"10.1016\/j.bjid.2024.103719_bib0032","first-page":"405","article-title":"Neutropenia in human immunodeficiency virus infection: data from the women's interagency HIV study","volume":"166","author":"Levine","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.bjid.2024.103719_bib0033","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1080\/21645515.2021.1891752","article-title":"Yellow fever virus vaccination: an emblematic model to elucidate robust human immune responses","volume":"17","author":"Bovay","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.bjid.2024.103719_bib0034","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1002\/eji.201142306","article-title":"The early cellular signatures of protective immunity induced by live viral vaccination","volume":"42","author":"Kohler","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.bjid.2024.103719_bib0035","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1590\/S0074-02762005000300021","article-title":"Lymphocyte subset analyses in healthy adults vaccinated with yellow fever 17DD virus","volume":"100","author":"Santos","year":"2005","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.bjid.2024.103719_bib0036","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.molimm.2023.10.013","article-title":"Differential gene expression of cytokines, receptors, and miRNAs in individuals living with HIV-1 and vaccinated against yellow fever","volume":"164","author":"Macieira","year":"2023","journal-title":"Mol Immunol"},{"key":"10.1016\/j.bjid.2024.103719_bib0037","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1096-9071(199810)56:2<159::AID-JMV10>3.0.CO;2-B","article-title":"Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection","volume":"56","author":"Reinhardt","year":"1998","journal-title":"J Med Virol"},{"key":"10.1016\/j.bjid.2024.103719_bib0038","doi-asserted-by":"crossref","first-page":"e2858","DOI":"10.1371\/journal.pntd.0002858","article-title":"The role of platelets in the pathogenesis of viral hemorrhagic fevers","volume":"8","author":"Zapata","year":"2014","journal-title":"PLoS Negl Trop Dis"}],"container-title":["The Brazilian Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867024000023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867024000023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T16:00:14Z","timestamp":1761408014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1413867024000023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S1413867024000023"],"URL":"https:\/\/doi.org\/10.1016\/j.bjid.2024.103719","relation":{},"ISSN":["1413-8670"],"issn-type":[{"value":"1413-8670","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of the yellow fever vaccine in people living with HIV: a longitudinal study exploring post-vaccination viremia and hematological and liver kinetics","name":"articletitle","label":"Article Title"},{"value":"The Brazilian Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjid.2024.103719","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Sociedade Brasileira de Infectologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"103719"}}